Global Effervescent Tablet Market 2024-2028

The effervescent tablet market is forecasted to grow by USD 4.80 bn during 2023-2028, accelerating at a CAGR of 8.36% during the forecast period. The report on the effervescent tablet market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption of effervescent tablets among the aging population, the advantages of effervescent tablets over regular tablets, and the rising prevalence of chronic diseases.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.84%
CAGR	8.36%
Incremental Value	$4.80bn

Technavio's effervescent tablet market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Type

Prescription
Over the counter

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the availability of effervescent supplements for youth and children as one of the prime reasons driving the effervescent tablet market growth during the next few years. Also, development of organic effervescent tablets and increasing popularity of effervescent tablets on online channels will lead to sizable demand in the market.

The report on the effervescent tablet market covers the following areas:

Effervescent tablet market sizing
Effervescent tablet market forecast
Effervescent tablet market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading effervescent tablet market vendors that include Alturix Ltd., Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc., HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, SciTech Specialities Pvt Ltd., Strava Healthcare Pvt. Ltd., S. G. Biopharm Pvt. Ltd., Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories. Also, the effervescent tablet market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74506

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global effervescent tablet market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global effervescent tablet market 2018 - 2022 ($ billion)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacy - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacy - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacy - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 48: Chart on Type - Market share 2023-2028 (%)
Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Prescription - Market size and forecast 2023-2028
Exhibit 52: Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Prescription - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
7.4 Over the counter - Market size and forecast 2023-2028
Exhibit 56: Chart on Over the counter - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Over the counter - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Over the counter - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Over the counter - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 60: Market opportunity by Type ($ billion)
Exhibit 61: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 India - Market size and forecast 2023-2028
Exhibit 87: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on India - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Alturix Ltd.
Exhibit 111: Alturix Ltd. - Overview
Exhibit 112: Alturix Ltd. - Product / Service
Exhibit 113: Alturix Ltd. - Key offerings
12.4 Bayer AG
Exhibit 114: Bayer AG - Overview
Exhibit 115: Bayer AG - Business segments
Exhibit 116: Bayer AG - Key news
Exhibit 117: Bayer AG - Key offerings
Exhibit 118: Bayer AG - Segment focus
12.5 Bliss GVS Pharma Ltd.
Exhibit 119: Bliss GVS Pharma Ltd. - Overview
Exhibit 120: Bliss GVS Pharma Ltd. - Business segments
Exhibit 121: Bliss GVS Pharma Ltd. - Key offerings
Exhibit 122: Bliss GVS Pharma Ltd. - Segment focus
12.6 Bristol Myers Squibb Co.
Exhibit 123: Bristol Myers Squibb Co. - Overview
Exhibit 124: Bristol Myers Squibb Co. - Product / Service
Exhibit 125: Bristol Myers Squibb Co. - Key news
Exhibit 126: Bristol Myers Squibb Co. - Key offerings
12.7 CHIESI Farmaceutici SpA
Exhibit 127: CHIESI Farmaceutici SpA - Overview
Exhibit 128: CHIESI Farmaceutici SpA - Product / Service
Exhibit 129: CHIESI Farmaceutici SpA - Key offerings
12.8 GlaxoSmithKline Plc
Exhibit 130: GlaxoSmithKline Plc - Overview
Exhibit 131: GlaxoSmithKline Plc - Business segments
Exhibit 132: GlaxoSmithKline Plc - Key news
Exhibit 133: GlaxoSmithKline Plc - Key offerings
Exhibit 134: GlaxoSmithKline Plc - Segment focus
12.9 HERMES PHARMA GmbH
Exhibit 135: HERMES PHARMA GmbH - Overview
Exhibit 136: HERMES PHARMA GmbH - Product / Service
Exhibit 137: HERMES PHARMA GmbH - Key offerings
12.10 Natur Produkt Zdrovit Sp Z O O
Exhibit 138: Natur Produkt Zdrovit Sp Z O O - Overview
Exhibit 139: Natur Produkt Zdrovit Sp Z O O - Product / Service
Exhibit 140: Natur Produkt Zdrovit Sp Z O O - Key offerings
12.11 Nestle SA
Exhibit 141: Nestle SA - Overview
Exhibit 142: Nestle SA - Business segments
Exhibit 143: Nestle SA - Key news
Exhibit 144: Nestle SA - Key offerings
Exhibit 145: Nestle SA - Segment focus
12.12 Novartis AG
Exhibit 146: Novartis AG - Overview
Exhibit 147: Novartis AG - Business segments
Exhibit 148: Novartis AG - Key offerings
Exhibit 149: Novartis AG - Segment focus
12.13 Perrigo Co. Plc
Exhibit 150: Perrigo Co. Plc - Overview
Exhibit 151: Perrigo Co. Plc - Business segments
Exhibit 152: Perrigo Co. Plc - Key news
Exhibit 153: Perrigo Co. Plc - Key offerings
Exhibit 154: Perrigo Co. Plc - Segment focus
12.14 Pfizer Inc.
Exhibit 155: Pfizer Inc. - Overview
Exhibit 156: Pfizer Inc. - Product / Service
Exhibit 157: Pfizer Inc. - Key news
Exhibit 158: Pfizer Inc. - Key offerings
12.15 Reckitt Benckiser Group Plc
Exhibit 159: Reckitt Benckiser Group Plc - Overview
Exhibit 160: Reckitt Benckiser Group Plc - Business segments
Exhibit 161: Reckitt Benckiser Group Plc - Key offerings
Exhibit 162: Reckitt Benckiser Group Plc - Segment focus
12.16 S. G. Biopharm Pvt. Ltd.
Exhibit 163: S. G. Biopharm Pvt. Ltd. - Overview
Exhibit 164: S. G. Biopharm Pvt. Ltd. - Product / Service
Exhibit 165: S. G. Biopharm Pvt. Ltd. - Key offerings
12.17 SciTech Specialities Pvt Ltd.
Exhibit 166: SciTech Specialities Pvt Ltd. - Overview
Exhibit 167: SciTech Specialities Pvt Ltd. - Product / Service
Exhibit 168: SciTech Specialities Pvt Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations